AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 17495183 — intervention group
Group type: EXPERIMENTAL
Intervention: Genotypes associated with higher 2-hour plasma glucose levels (rs2073162-A, rs2073163-C, rs1155974-T)
Number of subjects: 507
Study 17495183 — intervention group
Group type: EXPERIMENTAL
Intervention: Markers from haploblock 1 (rs5966709, rs4828037)
Number of subjects: 507
Study 17495183 — intervention group
Group type: EXPERIMENTAL
Intervention: Markers from haploblock 1 (rs11798018)
Number of subjects: 507
Study 17495183 — intervention group
Group type: EXPERIMENTAL
Intervention: Markers from haploblock 2 (rs2073163, rs1155794)
Number of subjects: 507
Study 17495183 — intervention group
Group type: EXPERIMENTAL
Intervention: Markers rs2073163, rs1155794, and rs2073162
Number of subjects: 507
Study 15263905 — intervention group
Group type: EXPERIMENTAL
Intervention: SLC6A4 genotype with social stressors and chronic diseases in females
Number of subjects: 1005
Study 15263905 — intervention group
Group type: COMPARATOR
Intervention: SLC6A4 genotype
Number of subjects: 1005
Study 11951802 — intervention group
Group type: EXPERIMENTAL
Intervention: Chicago IV gold alloy superstructures
Number of subjects: 26
Study 11951802 — intervention group
Group type: COMPARATOR
Intervention: Palliag M silver-palladium alloy superstructures
Number of subjects: 26
Study 10419078 — intervention group
Group type: EXPERIMENTAL
Intervention: Losartan 50 mg once daily for 4 weeks
Number of subjects: 60
Study 10419078 — intervention group
Group type: EXPERIMENTAL
Intervention: Eprosartan 600 mg once daily for 4 weeks
Number of subjects: 60
Study 7576427 — intervention group
Group type: EXPERIMENTAL
Intervention: PARTY-PLUS
Number of subjects: 0
Study 7576427 — intervention group
Group type: COMPARATOR
Intervention: Placebo (light mineral water)
Number of subjects: 0
Study 31433496 — intervention group
Group type: EXPERIMENTAL
Intervention: Blinatumomab
Number of subjects: 97
Study 31433496 — intervention group
Group type: COMPARATOR
Intervention: Standard-of-care (SOC) chemotherapy
Number of subjects: 97
Study 28884268 — intervention group
Group type: EXPERIMENTAL
Intervention: Parenting intervention for families of preschoolers at risk for conduct problems
Number of subjects: 99
Study 28884268 — intervention group
Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 99
Study 26747438 — intervention group
Group type: EXPERIMENTAL
Intervention: True bifurcation lesions (TBL) treated with second-generation drug-eluting stents (DES)
Number of subjects: 287
Study 26747438 — intervention group
Group type: COMPARATOR
Intervention: Non-true bifurcation lesions (non-TBL) treated with second-generation drug-eluting stents (DES)
Number of subjects: 287
Study 26747438 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with TBL and non-TBL
Number of subjects: 287
Study 26225004 — intervention group
Group type: EXPERIMENTAL
Intervention: Pregabalin (PGB)
Number of subjects: 22
Study 26225004 — intervention group
Group type: EXPERIMENTAL
Intervention: Lamotrigine (LTG)
Number of subjects: 22
Study 26225004 — intervention group
Group type: COMPARATOR
Intervention: Pregabalin (PGB) with Carbamazepine (CBZ)
Number of subjects: 22
Study 26225004 — intervention group
Group type: COMPARATOR
Intervention: Lamotrigine (LTG) with Carbamazepine (CBZ)
Number of subjects: 22
Study 22721577 — intervention group
Group type: EXPERIMENTAL
Intervention: Financial incentives and Internet-based counseling
Number of subjects: 800
Study 22721577 — intervention group
Group type: COMPARATOR
Intervention: Control group (no financial incentives)
Number of subjects: 800
Study 19744507 — intervention group
Group type: EXPERIMENTAL
Intervention: Electronic TV time monitor for 6 weeks with advice to restrict TV watching to 1 hour per day or less
Number of subjects: 29
Study 19744507 — intervention group
Group type: COMPARATOR
Intervention: Verbal advice to restrict TV watching
Number of subjects: 29
Study 19744507 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 29
Study 17515743 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-intensity intramuscular electrostimulation applied to the myofascial trigger point (MTP) with an interstimulus interval of 0.5 s.
Number of subjects: 24
Study 15338221 — intervention group
Group type: COMPARATOR
Intervention: Control subjects (n=12)
Number of subjects: 28
Study 15338221 — intervention group
Group type: EXPERIMENTAL
Intervention: UEMSD cases without cold hands (n=10)
Number of subjects: 28
Study 15338221 — intervention group
Group type: EXPERIMENTAL
Intervention: UEMSD cases with cold hands (n=6)
Number of subjects: 28
Study 11675834 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral anticoagulant treatment (maintaining INR between 2.0 and 3.0)
Number of subjects: 0
Study 11675834 — intervention group
Group type: COMPARATOR
Intervention: Aspirin or other antiplatelet agents
Number of subjects: 0
Study 9711469 — intervention group
Group type: EXPERIMENTAL
Intervention: Bisoprolol
Number of subjects: 15
Study 9711469 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study 7974947 — intervention group
Group type: EXPERIMENTAL
Intervention: Yohimbine (15 mg per day orally) and trazodone (50 mg per day orally)
Number of subjects: 63
Study 7974947 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 63
Study 7974947 — intervention group
Group type: EXPERIMENTAL
Intervention: Yohimbine and trazodone
Number of subjects: 63
Study 3198868 — intervention group
Group type: EXPERIMENTAL
Intervention: Sinusoids of fixed frequency whose level was swept up or down by 5 or 10 dB
Number of subjects: 4
Study 3198868 — intervention group
Group type: EXPERIMENTAL
Intervention: Sinusoids of fixed level whose frequency was swept up or down by 100 Hz
Number of subjects: 4
Study 3198868 — intervention group
Group type: EXPERIMENTAL
Intervention: Sinusoids whose level was swept up or down by 10 dB and whose frequency was swept up or down by 100 Hz
Number of subjects: 4
Study 3198868 — intervention group
Group type: COMPARATOR
Intervention: Fixed signal (sinusoids fixed in frequency and level)
Number of subjects: 4
Study 3198868 — intervention group
Group type: EXPERIMENTAL
Intervention: Rate of change in frequency and/or level
Number of subjects: 4
Study 4609555 — intervention group
Group type: EXPERIMENTAL
Intervention: 95% alcoholic chlorhexidine (0.5%)
Number of subjects: 0
Study 4609555 — intervention group
Group type: EXPERIMENTAL
Intervention: Tetrabrom‐o‐methyl phenol (0.1%)
Number of subjects: 0
Study 4609555 — intervention group
Group type: EXPERIMENTAL
Intervention: 95% alcoholic chlorhexidine (0.5%) after six treatments
Number of subjects: 0
Study 4609555 — intervention group
Group type: EXPERIMENTAL
Intervention: Tetrabrom‐o‐methyl phenol (0.1%) after six treatments
Number of subjects: 0
Study 4609555 — intervention group
Group type: COMPARATOR
Intervention: 4% chlorhexidine detergent solution
Number of subjects: 0
Study 4609555 — intervention group
Group type: COMPARATOR
Intervention: 95% or 70% ethyl alcohol
Number of subjects: 0
Study 4609555 — intervention group
Group type: COMPARATOR
Intervention: Aqueous 0.5% chlorhexidine
Number of subjects: 0
Study 4609555 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcoholic chlorhexidine vs. tetrabrom‐o‐methyl phenol
Number of subjects: 0
Study 4609555 — intervention group
Group type: COMPARATOR
Intervention: 70% ethyl alcohol
Number of subjects: 0
Study 31523754 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioral outcomes from pooled dataset
Number of subjects: 1974
Study 31523754 — intervention group
Group type: EXPERIMENTAL
Intervention: Substance use behaviors from pooled dataset
Number of subjects: 1974
Study 31523754 — intervention group
Group type: EXPERIMENTAL
Intervention: STI acquisition from pooled dataset
Number of subjects: 1974
Study 31060644 — intervention group
Group type: EXPERIMENTAL
Intervention: Adverse childhood experiences (ACEs)
Number of subjects: 36
Study 31060644 — intervention group
Group type: EXPERIMENTAL
Intervention: Duration of opioid use
Number of subjects: 36
Study 28167196 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified Pilates exercises, three times a week for eight weeks
Number of subjects: 50
Study 28167196 — intervention group
Group type: COMPARATOR
Intervention: Control group (no Pilates intervention)
Number of subjects: 50
Study 28167196 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group (Pilates)
Number of subjects: 50
Study 28167196 — intervention group
Group type: COMPARATOR
Intervention: Comparison between control and intervention groups after intervention
Number of subjects: 50
Study 24124665 — intervention group
Group type: EXPERIMENTAL
Intervention: Tilt angle 60°
Number of subjects: 174
Study 24124665 — intervention group
Group type: EXPERIMENTAL
Intervention: Tilt angle 70°
Number of subjects: 174
Study 24124665 — intervention group
Group type: EXPERIMENTAL
Intervention: Tilt angle 80°
Number of subjects: 174
Study 24124665 — intervention group
Group type: EXPERIMENTAL
Intervention: Tilt angles 60°, 70°, and 80°
Number of subjects: 174
Study 24183707 — intervention group
Group type: EXPERIMENTAL
Intervention: Metacognitive Training (MCT)
Number of subjects: 150
Study 24183707 — intervention group
Group type: COMPARATOR
Intervention: Cognitive Training (Control)
Number of subjects: 150
Study 21457084 — intervention group
Group type: EXPERIMENTAL
Intervention: Retroperitoneal laparoscopic ureterolithotomy (RLU) without stent placement (Group 1)
Number of subjects: 104
Study 21457084 — intervention group
Group type: COMPARATOR
Intervention: Retroperitoneal laparoscopic ureterolithotomy (RLU) with stent placement (Group 2)
Number of subjects: 104
Study 18642974 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 mg long-acting risperidone administered intramuscularly once a month
Number of subjects: 7
Study 17003713 — intervention group
Group type: EXPERIMENTAL
Intervention: Tonsillotomy (TT)
Number of subjects: 92
Study 17003713 — intervention group
Group type: COMPARATOR
Intervention: Total tonsillectomy (TE)
Number of subjects: 92
Study 14559073 — intervention group
Group type: EXPERIMENTAL
Intervention: Severe envenomation with MOD
Number of subjects: 46
Study 14559073 — intervention group
Group type: EXPERIMENTAL
Intervention: Mild envenomation
Number of subjects: 46
Study 14559073 — intervention group
Group type: COMPARATOR
Intervention: Control group (healthy children)
Number of subjects: 46
Study 14559073 — intervention group
Group type: EXPERIMENTAL
Intervention: All victims (severe and mild)
Number of subjects: 46
Study 14559073 — intervention group
Group type: EXPERIMENTAL
Intervention: Severely envenomed children with MOD
Number of subjects: 46
Study 14559073 — intervention group
Group type: EXPERIMENTAL
Intervention: Case fatality rate
Number of subjects: 46
Study 14559073 — intervention group
Group type: EXPERIMENTAL
Intervention: LODS score
Number of subjects: 46
Study 14559073 — intervention group
Group type: EXPERIMENTAL
Intervention: sFas and Bcl‐2
Number of subjects: 46
Study 10801241 — intervention group
Group type: EXPERIMENTAL
Intervention: Alprazolam with low-dose ritonavir (200 mg, four doses)
Number of subjects: 0
Study 10801241 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 8653994 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral contraceptive steroids
Number of subjects: 12
Study 8653994 — intervention group
Group type: COMPARATOR
Intervention: Non-users of oral contraceptive steroids
Number of subjects: 12
Study 1728021 — intervention group
Group type: COMPARATOR
Intervention: Conventional ventilation (CV)
Number of subjects: 83
Study 1728021 — intervention group
Group type: EXPERIMENTAL
Intervention: High-frequency oscillatory ventilation (HFOV) only
Number of subjects: 83
Study 1728021 — intervention group
Group type: EXPERIMENTAL
Intervention: HFOV for 72 hours followed by CV (HFOV/CV)
Number of subjects: 83
Study 6144975 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin (ASA, 100 mg daily)
Number of subjects: 83
Study 6144975 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 83
Study 30248030 — intervention group
Group type: EXPERIMENTAL
Intervention: Suboccipital muscle inhibition (SMI) technique
Number of subjects: 20
Study 30248030 — intervention group
Group type: EXPERIMENTAL
Intervention: Cranio-cervical flexion exercise (CCFE)
Number of subjects: 20
Study 27733107 — intervention group
Group type: EXPERIMENTAL
Intervention: Mizoribine (12 mg/kg/d)
Number of subjects: 83
Study 27733107 — intervention group
Group type: COMPARATOR
Intervention: Mycophenolate mofetil (2000 mg/d)
Number of subjects: 83
Study 27733107 — intervention group
Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 83
Study 24435069 — intervention group
Group type: EXPERIMENTAL
Intervention: Shoe advice leaflet
Number of subjects: 57
Study 24435069 — intervention group
Group type: COMPARATOR
Intervention: No leaflet (control group)
Number of subjects: 57
Study 23039171 — intervention group
Group type: EXPERIMENTAL
Intervention: Imatinib mesylate 400 mg daily for 6 months
Number of subjects: 28
Study 23039171 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 28
Study 20129738 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mg hydrocortisone (cortisol group)
Number of subjects: 48
Study 20129738 — intervention group
Group type: COMPARATOR
Intervention: Placebo (placebo group)
Number of subjects: 48
Study 20129738 — intervention group
Group type: EXPERIMENTAL
Intervention: Cortisol group
Number of subjects: 48
Study 20129738 — intervention group
Group type: COMPARATOR
Intervention: Placebo group
Number of subjects: 48
Study 18601750 — intervention group
Group type: EXPERIMENTAL
Intervention: True auriculopressure
Number of subjects: 0
Study 18601750 — intervention group
Group type: COMPARATOR
Intervention: Placebo auriculopressure
Number of subjects: 0
Study 15243564 — intervention group
Group type: EXPERIMENTAL
Intervention: Asymptomatic unilateral tonsillar enlargement
Number of subjects: 104
Study 15243564 — intervention group
Group type: COMPARATOR
Intervention: Symmetric tonsils (control group)
Number of subjects: 104
Study 12567797 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behavioural Therapy (CBT), 12 sessions
Number of subjects: 38
Study 12567797 — intervention group
Group type: COMPARATOR
Intervention: Waiting list control group
Number of subjects: 38
Study 9425916 — intervention group
Group type: EXPERIMENTAL
Intervention: Transjugular intrahepatic portosystemic shunt (TIPS)
Number of subjects: 81
Study 9425916 — intervention group
Group type: COMPARATOR
Intervention: Endoscopic sclerotherapy
Number of subjects: 81
Study 8125726 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone 0.5 mg every 6 hours
Number of subjects: 20
Study 8125726 — intervention group
Group type: COMPARATOR
Intervention: Placebo every 6 hours
Number of subjects: 20
Study 8125726 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone
Number of subjects: 20
Study 8125726 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 2486583 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.125% bupivacaine at 20 ml/hr (25 mg/hr)
Number of subjects: 23
Study 2486583 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.25% bupivacaine at 10 ml/hr (25 mg/hr)
Number of subjects: 23
Study 2486583 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 mg bupivacaine loading dose followed by 25 mg/hr
Number of subjects: 23
Study 2486583 — intervention group
Group type: EXPERIMENTAL
Intervention: Supplemental boluses of 4 ml of 0.5% bupivacaine
Number of subjects: 23
Study 153729 — intervention group
Group type: EXPERIMENTAL
Intervention: iodochlorhydroxyquin-hydrocortisone cream
Number of subjects: 354
Study 153729 — intervention group
Group type: EXPERIMENTAL
Intervention: iodochlorhydroxyquin cream
Number of subjects: 354
Study 153729 — intervention group
Group type: COMPARATOR
Intervention: hydrocortisone
Number of subjects: 354
Study 153729 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 354
Study 31604130 — intervention group
Group type: EXPERIMENTAL
Intervention: Chloroquine (CQ) and primaquine (PQ) treatment (3-day CQ and 14-day PQ at 3.5 mg/kg total dose) as directly observed therapy
Number of subjects: 281
Study 28974462 — intervention group
Group type: EXPERIMENTAL
Intervention: Problem-solving intervention for family members of hospice patients
Number of subjects: 73
Study 28974462 — intervention group
Group type: COMPARATOR
Intervention: Adult family home setting
Number of subjects: 73
Study 26294102 — intervention group
Group type: EXPERIMENTAL
Intervention: Argon laser peripheral iridoplasty (ALPI)
Number of subjects: 30
Study 26294102 — intervention group
Group type: COMPARATOR
Intervention: Conventional medical therapy
Number of subjects: 30
Study 24627405 — intervention group
Group type: EXPERIMENTAL
Intervention: Domain-based language training for 6 months
Number of subjects: 728
Study 24627405 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 728
Study 24627405 — intervention group
Group type: COMPARATOR
Intervention: Baseline study group (no intervention)
Number of subjects: 728
Study 23744591 — intervention group
Group type: EXPERIMENTAL
Intervention: Parathyroidectomy (PTx)
Number of subjects: 24
Study 23744591 — intervention group
Group type: COMPARATOR
Intervention: Conservative follow-up
Number of subjects: 24
Study 23744591 — intervention group
Group type: COMPARATOR
Intervention: Control group (age- and sex-matched)
Number of subjects: 24
Study 20010120 — intervention group
Group type: EXPERIMENTAL
Intervention: HOT (40 degrees C, 25% RH)
Number of subjects: 8
Study 20010120 — intervention group
Group type: COMPARATOR
Intervention: TEMP (21 degrees C, 50% RH)
Number of subjects: 8
Study 20010120 — intervention group
Group type: EXPERIMENTAL
Intervention: Both environments
Number of subjects: 8
Study 18188753 — intervention group
Group type: EXPERIMENTAL
Intervention: Telephone-support group (n = 118)
Number of subjects: 228
Study 18188753 — intervention group
Group type: COMPARATOR
Intervention: Self-help-only group (n = 110)
Number of subjects: 228
Study 16163445 — intervention group
Group type: EXPERIMENTAL
Intervention: Sentinel node biopsy (SNB)
Number of subjects: 829
Study 16163445 — intervention group
Group type: COMPARATOR
Intervention: Standard axillary treatment (level I‐III axillary lymph node dissection or four node sampling)
Number of subjects: 829
Study 14551846 — intervention group
Group type: EXPERIMENTAL
Intervention: Dorsal fusion with fixateur intern and autologous bone (74 patients)
Number of subjects: 97
Study 14551846 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined dorso-ventral fusion with intervertebral fusion and tricortical autologous bone (23 patients)
Number of subjects: 97
Study 14551846 — intervention group
Group type: EXPERIMENTAL
Intervention: Oswestry score for clinical outcome
Number of subjects: 97
Study 10924613 — intervention group
Group type: EXPERIMENTAL
Intervention: 15-loci STR panel
Number of subjects: 126
Study 10924613 — intervention group
Group type: COMPARATOR
Intervention: Random pairs
Number of subjects: 126
Study 10924613 — intervention group
Group type: EXPERIMENTAL
Intervention: Sibling group
Number of subjects: 126
Study 10924613 — intervention group
Group type: COMPARATOR
Intervention: Random group
Number of subjects: 126
Study 10924613 — intervention group
Group type: COMPARATOR
Intervention: Unrelated pairs
Number of subjects: 126
Study 8830942 — intervention group
Group type: EXPERIMENTAL
Intervention: Transient (phasic) bell-shaped VESTEP recorded during backward-tilts in Earth-bound laboratory conditions.
Number of subjects: 90
Study 8830942 — intervention group
Group type: EXPERIMENTAL
Intervention: Sustained (tonic) negativity found during nose-down tilts in Earth-bound conditions.
Number of subjects: 90
Study 8830942 — intervention group
Group type: EXPERIMENTAL
Intervention: Transient bell-shaped responses recorded in microgravity irrespective of tilt direction.
Number of subjects: 90
Study 1339126 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrogen peroxide-containing toothpaste (0.67% hydrogen peroxide and 5.48% sodium bicarbonate)
Number of subjects: 10
Study 1339126 — intervention group
Group type: COMPARATOR
Intervention: Fluoride control paste (standard silica based toothpaste containing 1500 ppm F as sodium monofluorophosphate)
Number of subjects: 10
Study 6738835 — intervention group
Group type: EXPERIMENTAL
Intervention: Vasopressin
Number of subjects: 1
Study 6738835 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1
Study 30107241 — intervention group
Group type: EXPERIMENTAL
Intervention: Internet-delivered exposure therapy (iExp)
Number of subjects: 140
Study 30107241 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control (WLC)
Number of subjects: 140
Study 29522919 — intervention group
Group type: EXPERIMENTAL
Intervention: Mechanomyography (MMG) ratio
Number of subjects: 10
Study 25891265 — intervention group
Group type: EXPERIMENTAL
Intervention: Target depicted as lacking moral status
Number of subjects: 0
Study 25891265 — intervention group
Group type: EXPERIMENTAL
Intervention: Target depicted as high in morality
Number of subjects: 0
Study 25891265 — intervention group
Group type: COMPARATOR
Intervention: Control condition with no information about the target's moral qualities
Number of subjects: 0
Study 25891265 — intervention group
Group type: EXPERIMENTAL
Intervention: Information on another evaluative dimension (competence)
Number of subjects: 0
Study 25891265 — intervention group
Group type: EXPERIMENTAL
Intervention: Social targets perceived as lacking moral qualities
Number of subjects: 0
Study 24648506 — intervention group
Group type: EXPERIMENTAL
Intervention: Amoxicillin thrice daily (50 mg/kg/day)
Number of subjects: 820
Study 24648506 — intervention group
Group type: COMPARATOR
Intervention: Amoxicillin twice daily (50 mg/kg/day)
Number of subjects: 820
Study 22683195 — intervention group
Group type: EXPERIMENTAL
Intervention: Iomeprol 400 mgI/mL (100 mL)
Number of subjects: 110
Study 22683195 — intervention group
Group type: COMPARATOR
Intervention: Iodixanol 320 mgI/mL (125 mL)
Number of subjects: 110
Study 20492615 — intervention group
Group type: EXPERIMENTAL
Intervention: PRT-PLTs
Number of subjects: 118
Study 20492615 — intervention group
Group type: COMPARATOR
Intervention: Reference group
Number of subjects: 118
Study 18803866 — intervention group
Group type: EXPERIMENTAL
Intervention: B-vitamin supplementation (folic acid 2 mg, vitamin B6 25 mg, vitamin B12 0.5 mg)
Number of subjects: 162
Study 18803866 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 162
Study 18803866 — intervention group
Group type: EXPERIMENTAL
Intervention: B-vitamin supplementation
Number of subjects: 162
Study 18803866 — intervention group
Group type: EXPERIMENTAL
Intervention: B-vitamin supplementation (meta-analysis)
Number of subjects: 162
Study 15695545 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined ilioinguinal blockade and local infiltration anaesthesia
Number of subjects: 160
Study 15695545 — intervention group
Group type: COMPARATOR
Intervention: Placebo (local infiltration anaesthesia only)
Number of subjects: 160
Study 11886733 — intervention group
Group type: EXPERIMENTAL
Intervention: Initial training on a manikin with computer-based voice advisory feedback
Number of subjects: 35